COVID-19 convalescent plasma
코로나19 회복기 혈장
Article
[키워드] Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antibody
antibody-dependent cellular cytotoxicity
benefit
CCP
collected
complement
Complement activation
convalescent plasma
coronavirus
coronavirus disease
COVID-19
disease
early disease
Efficacy
function
Health
Health crisis
high-titer CCP
Hospitalized
Immunosuppressed
immunosuppressed patient
immunosuppressed patients
indications
location
moderate
moderate to severe
Outpatient
pandemic
phagocytosis
plasma
prophylactic therapy
provide
provided
randomized trial
respiratory
safety profile
SARS-CoV-2
SARS-CoV-2 variants
severe acute respiratory syndrome Coronavirus
severe disease
symptom onset
the patient
The United States
therapeutic potential
Therapies
transfused
Treatment
Trial
United States
Viral
viral neutralization
with COVID-19
[DOI] 10.1182/blood.2021012248 PMC 바로가기 [Article Type] Article
[DOI] 10.1182/blood.2021012248 PMC 바로가기 [Article Type] Article